March 10, 2026 · Form 4 insider transaction
KENNEY CHRISTOPHER JOHN sold 2,771 shares of XENON PHARMACEUTICALS INC at $60.11 per share, a transaction worth $166.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.